Flashpoint Strengthens Leadership with Appointment of Barry Labinger as Chief Executive Officer
- bancheta6
- Jul 30
- 1 min read
Evanston, IL, July 29, 2025 (Business Wire) -- Flashpoint Therapeutics named Barry Labinger as CEO, bringing decades of executive experience in biopharma Labinger brings over 30 years of leadership experience across the biopharmaceutical sector, having steered multiple organizations through high-growth phases, IPOs, and the clinical advancement of novel therapeutics. His most recent roles, including CEO at Gilboa Therapeutics and Checkmate Pharmaceuticals, underscore a consistent trajectory of strategic execution in oncology and immunotherapy, complemented by foundational leadership roles at major firms such as Bristol Myers Squibb and Abbott Laboratories.
Read full article here.
Comments